Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands
- PMID: 24394734
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands
Abstract
Introduction: According to the Dutch guidelines, severity of community acquired pneumonia (CAP) (mild, moderate-severe, severe) should be based on either PSI, CURB65 or a 'pragmatic' classification. In the last mentioned, the type of ward of admission, as decided by the treating physician, is used as classifier: no hospital admission is mild, admission to a general ward is moderate-severe and admission to an intensive care unit (ICU) is severe CAP. Empiric antibiotic recommendations for each severity class are uniform. We investigated, in 23 hospitals, which of the three classification systems empirical treatment of CAP best adhered to, and whether a too narrow spectrum coverage (according to each of the systems) was associated with a poor patient outcome (in-hospital mortality or need for ICU admission).
Patients and methods: Prospective observational study in 23 hospitals.
Results: 271 (26%) of 1047 patients with CAP confirmed by X-ray were categorised in the same severity class with all three classification methods. Proportions of patients receiving guideline-adherent antibiotics were 62.9% (95% CI 60.0-65.8%) for the pragmatic, 43.1% (95% CI 40.1-46.1%) for PSI and 30.5% (95% CI 27.8-33.3%) for CURB65 classification. 'Under-treatment' based on the pragmatic classification was associated with a trend towards poor clinical outcome, but no such trend was apparent for the other two scoring systems.
Conclusions: Concordance between three CAP severity classification systems was low, implying large heterogeneity in antibiotic treatment for CAP patients. Empirical treatment appeared most adherent to the pragmatic classification. Non-adherence to treatment recommendations based on the PSI and CURB65 was not associated with a poor clinical outcome.
Similar articles
-
Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.Respir Med. 2007 Sep;101(9):1909-15. doi: 10.1016/j.rmed.2007.04.018. Epub 2007 Jul 12. Respir Med. 2007. PMID: 17628462
-
Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals.Diagn Microbiol Infect Dis. 2006 Apr;54(4):267-75. doi: 10.1016/j.diagmicrobio.2005.10.007. Epub 2006 Feb 8. Diagn Microbiol Infect Dis. 2006. PMID: 16466891
-
Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals.Can Respir J. 2004 Mar;11(2):131-7. doi: 10.1155/2004/970828. Can Respir J. 2004. PMID: 15045044
-
[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].Ned Tijdschr Geneeskd. 2005 Nov 5;149(45):2495-500. Ned Tijdschr Geneeskd. 2005. PMID: 16304886 Review. Dutch.
-
Community acquired bacterial pneumonia.Expert Opin Pharmacother. 2010 Feb;11(3):361-74. doi: 10.1517/14656560903508770. Expert Opin Pharmacother. 2010. PMID: 20085502 Review.
Cited by
-
Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future.JAC Antimicrob Resist. 2021 Jun 14;3(2):dlab080. doi: 10.1093/jacamr/dlab080. eCollection 2021 Jun. JAC Antimicrob Resist. 2021. PMID: 34223139 Free PMC article.
-
Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study.BMC Pulm Med. 2017 Apr 20;17(1):66. doi: 10.1186/s12890-017-0404-8. BMC Pulm Med. 2017. PMID: 28427381 Free PMC article.
-
A multifaceted intervention to reduce guideline non-adherence among prescribing physicians in Dutch hospitals.Int J Clin Pharm. 2017 Dec;39(6):1211-1219. doi: 10.1007/s11096-017-0553-0. Epub 2017 Nov 3. Int J Clin Pharm. 2017. PMID: 29101616 Free PMC article.
-
Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.Antimicrob Agents Chemother. 2014 Aug;58(8):4470-5. doi: 10.1128/AAC.02759-14. Epub 2014 May 27. Antimicrob Agents Chemother. 2014. PMID: 24867975 Free PMC article.
-
The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.Int J Infect Dis. 2021 Oct;111:196-203. doi: 10.1016/j.ijid.2021.08.060. Epub 2021 Aug 26. Int J Infect Dis. 2021. PMID: 34455081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous